BRAIN BIOTECH AG (BNN.DE) Stock Price, Forecast & Analysis
Europe - FRA:BNN - DE0005203947 - Common Stock
BNN.DE Key Statistics, Chart & Performance
The current stock price of BNN.DE is 3.04 EUR. In the past month the price increased by 13.89%. In the past year, price decreased by -16.61%.
BNN.DE Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| 1COV.DE | COVESTRO AG | N/A | 11.28B | ||
| SY1.DE | SYMRISE AG | 19.49 | 9.89B | ||
| AKZA.AS | AKZO NOBEL N.V. | 15.55 | 9.68B | ||
| SYENS.BR | SYENSQO SA | 13.35 | 7.31B | ||
| EVK.DE | EVONIK INDUSTRIES AG | 66.8 | 6.23B | ||
| UMI.BR | UMICORE | 14.94 | 4.16B | ||
| NVJP.DE | UMICORE | 15.25 | 4.25B | ||
| AKE.PA | ARKEMA | 9.67 | 3.80B | ||
| WCH.DE | WACKER CHEMIE AG | 157.21 | 3.53B | ||
| RBT.PA | ROBERTET SA | 18.37 | 1.87B | ||
| ACT.DE | ALZCHEM GROUP AG | 22.1 | 1.37B | ||
| CRBN.AS | CORBION NV | 16 | 1.04B |
Related stock screener links
About BNN.DE
Company Profile
BRAIN Biotech AG is a technology company, which engages in the development and commercialization of bioactives, natural compounds, and proprietary enzymes. The company is headquartered in Zwingenberg, Hessen and currently employs 284 full-time employees. The company went IPO on 2016-02-09. Biotechnology Research and Information Network AG, is a Germany -based Company. The firm is a supplier of bio-based products and solutions such as enzymes and proteins, microbial production strains, natural substances, and biotechnological solutions for industrial processes in the areas of nutrition, health, and the environment. BRAIN Biotech is also offers contract research and development in the fields of enzyme technology, microbial strain development and bioprocess development.
Company Info
BRAIN BIOTECH AG
Darmstaedter Strasse 34-36
Zwingenberg HESSEN DE
Employees: 284
Phone: 49625193310
BRAIN BIOTECH AG / BNN.DE FAQ
What does BNN do?
BRAIN Biotech AG is a technology company, which engages in the development and commercialization of bioactives, natural compounds, and proprietary enzymes. The company is headquartered in Zwingenberg, Hessen and currently employs 284 full-time employees. The company went IPO on 2016-02-09. Biotechnology Research and Information Network AG, is a Germany -based Company. The firm is a supplier of bio-based products and solutions such as enzymes and proteins, microbial production strains, natural substances, and biotechnological solutions for industrial processes in the areas of nutrition, health, and the environment. BRAIN Biotech is also offers contract research and development in the fields of enzyme technology, microbial strain development and bioprocess development.
What is the stock price of BRAIN BIOTECH AG today?
The current stock price of BNN.DE is 3.04 EUR. The price increased by 23.58% in the last trading session.
What is the dividend status of BRAIN BIOTECH AG?
BNN.DE does not pay a dividend.
What is the ChartMill technical and fundamental rating of BNN stock?
BNN.DE has a ChartMill Technical rating of 7 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
How is the market expecting BNN stock to perform?
9 analysts have analysed BNN.DE and the average price target is 5.73 EUR. This implies a price increase of 88.57% is expected in the next year compared to the current price of 3.04.
Can you provide the market cap for BRAIN BIOTECH AG?
BRAIN BIOTECH AG (BNN.DE) has a market capitalization of 66.42M EUR. This makes BNN.DE a Micro Cap stock.
BNN.DE Technical Analysis
ChartMill assigns a technical rating of 7 / 10 to BNN.DE. When comparing the yearly performance of all stocks, BNN.DE turns out to be only a medium performer in the overall market: it outperformed 48% of all stocks.
BNN.DE Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to BNN.DE. Both the profitability and financial health of BNN.DE have multiple concerns.
BNN.DE Financial Highlights
Over the last trailing twelve months BNN.DE reported a non-GAAP Earnings per Share(EPS) of -0.54. The EPS decreased by -33.27% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -17.27% | ||
| ROE | -227.22% | ||
| Debt/Equity | 0.74 |
BNN.DE Forecast & Estimates
9 analysts have analysed BNN.DE and the average price target is 5.73 EUR. This implies a price increase of 88.57% is expected in the next year compared to the current price of 3.04.
For the next year, analysts expect an EPS growth of 45.61% and a revenue growth -0.63% for BNN.DE